Advances in the treatment of travelers' diarrhea (Q37902952)

25 August 2017

1 reference

title

Advances in the treatment of travelers' diarrhea (English)

1 reference

25 August 2017

0 references

Mercedes Paredes-Paredes

series ordinal

1

1 reference

25 August 2017

Jose Flores-Figueroa

series ordinal

2

1 reference

25 August 2017

Herbert L Dupont

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

1 October 2011

1 reference

Current gastroenterology reports

25 August 2017

published in

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

402-407

1 reference

Economic aspects of travelers' diarrhea

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Gastrointestinal infection among international travelers globally

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Oral rehydration solutions in non-cholera diarrhea: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Expert review of the evidence base for self-therapy of travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Characterization of norovirus-associated traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Clostridium difficile-associated diarrhea after antibiotic treatment for traveler's diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Travelers' diarrhea in Nepal: an update on the pathogens and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Prulifloxacin: clinical studies of a broad-spectrum quinolone agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Efficacy of rifaximin compared with ciprofloxacin for the treatment of acute infectious diarrhea: a randomized controlled multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Antagonistic activity of Lactobacillus acidophilus RY2 isolated from healthy infancy feces on the growth and adhesion characteristics of enteroaggregative Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Lactobacillus acidophilus stimulates the expression of SLC26A3 via a transcriptional mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats : preventive effects of probiotics on TD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

Disease burden of post-infectious irritable bowel syndrome in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0208-6

The Incidence and Gastrointestinal Infectious Risk of Functional Gastrointestinal Disorders in a Healthy US Adult Population

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773708

12 December 2020

Defining infections in international travellers through the GeoSentinel surveillance network

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773708

12 December 2020

Fluoroquinolones: psychiatric adverse effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773708

12 December 2020

Global etiology of travelers' diarrhea: systematic review from 1973 to the present.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773708

12 December 2020

10.1007/S11894-011-0208-6

Identifiers

DOI

1 reference

25 August 2017

1 reference